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Co-Presentation of Biomolecules 
 Xiaopei Deng, Thomas W. Eyster, Yaseen Elkasabi, Joerg Lahann*  Controlled presentation of biomolecules on synthetic substrates is an important aspect for 
biomaterials development. If the immobilization of multiple biomolecules is required, highly 
efﬁ cient orthogonal surface chemistries are needed to ensure the precision of the immobi-
lization. In this communication, chemical vapor deposition (CVD) copolymerization is used 
to fabricate polymer coatings with controlled ratio of alkyne and pentaﬂ uorophenyl ester 
(Pfp-ester) groups. Cyclic argine-glycine-aspartic acid (cRGD) adhesion peptide and epidermal 
growth factor (EGF) are immobilized through alkyne–azide 
cycloaddtion (“click” chemistry) and active ester–amine reac-
tion, respectively. Cell studies with human umbilical vein 
endothelial cells (HUVEC) and A431 cell lines demonstrate 
the biological activity of the coimmobilized biomolecules.   1. Introduction 
 The fate of cells cultured in a synthetic environment is, at 
least in part, governed by interactions with biomolecules 
on the substrate surface. [ 1 ] The latter act as recognition sites 
that can induce and mitigate vital cellular functions such 
as adhesion, migration, and differentiation. [ 1b ] Potential  X.  Deng  
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stents, pacemakers, or grafts; use of polymer substrates for 
in vitro cell culture; [ 3 ] or design of bioanalytical tools such 
as microarrays for protein, DNA, or polysaccharide detec-
tion. [ 4 ] Because of the central role that cell–protein interac-
tions play in biology, advanced applications in medicine 
and biotechnology require precise presentation of sig-
naling molecules on the substrate surfaces. This revela-
tion fueled a wide range of research activities focused on 
the controlled presentation of biomolecules on synthetic 
substrates. Initial work has included physisorption of pro-
teins on substrate surfaces and covalent attachment using 
a number of nonspeciﬁ c crosslinking reactions. [ 5 ] More 
recent activities have taken advantage of novel immobi-
lization concepts, such as click chemistry, to achieve con-
trolled orientation of biomolecules on surfaces. [ 6 ] The high 
speciﬁ city of click reactions may potentially provide an 
additional advantage: the possibility of presenting a com-
bination of multiple biomolecules on the same surface 
using orthogonal chemical reactions, that is, reactions that 
do not show cross-reactivity toward their biological target 
molecules. [ 7 ] 
 Previously, we have developed chemical vapor depo-
sition (CVD) polymerization technology to coat a range 
of functionalized poly- p -xylylenes on a variety of sub-
strates. [ 8 ] These reactive coatings provide different func-
tional groups on different coatings that were used for  DOI: 10.1002/marc.201100819 brary.com
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 Scheme  1 .  CVD copolymerization of [2.2]paracyclophanes with pentaﬂ uorophenyl ester 
and alkyne groups; m  = n for the copolymer  3 discussed in this paper. immobilization of biomolecules such 
as peptides, proteins, and DNA. [ 2a , 8a , 9 ] 
Moreover, it has been established that 
CVD copolymerization of [2.2]paracyclo-
phanes containing different functional 
groups can be realized. This produces 
multipotent polymer coatings, which 
can be used for simultaneous presenta-
tion of multiple molecules in controlled 
ratios. [ 7b ] 
 With a number of speciﬁ c chemical 
reactions in hand, [ 10 ] the focus of bio-
medical engineers is now shifting from 
model systems to technology platforms that are equally 
applicable to a wide range of different substrate mate-
rials. Copper-catalyzed azide–alkyne 1,3-dipolar cycload-
dition is one of the bio-orthogonal reactions, as deﬁ ned by 
Sletten and Bertozzi. [ 7a ] The reaction is also known as one 
of the “click” reactions, [ 11 ] which are characterized by high 
reaction rate and selectivity. The azide–alkyne 1,3-dipolar 
cycloaddition has been used in a wide variety of applica-
tions, such as bioconjugation, drug design, organic syn-
thesis, and polymer design. [ 12 ] Pentaﬂ uorophenyl ester 
(Pfp-ester) groups are active esters commonly used in 
peptide synthesis, organic synthesis, polymer chemistry, 
and surface chemistry. [ 13 ] Pentaﬂ uorophenyl ester groups 
can rapidly react with amines to form amide bond with 
no side reactions under mild conditions thus suitable for 
one-step immobilizations of proteins onto surface. [ 13c ] 
 Vapor-based coatings provide an attractive solution to 
major requirements associated with biomolecule immo-
bilization applications, as they can result in ultrathin, 
conformal coatings that de facto decouple the surface 
properties from the underlying bulk material. [ 14 ] In this 
paper, we design a multifunctional coating for simulta-
neous click reaction and active ester chemistry to achieve 
co-presentation of epidermal growth factor (EGF) and 
cyclic argine-glycine-aspartic acid (cRDG) adhesion pep-
tides. Cell responses on the surface immobilized with two 
different biomolecules were then tested. (Scheme shown 
in Figure  2 a) Our approach builds on recent progress with 
CVD co-polymerization, to develop multifunctional coat-
ings that (1) can present two different biomolecules, that 
is, cyclic RGD peptide (cRGD) and epidermal growth factor 
(EGF); (2) offer orthogonal immobilization pathways; and 
(3) are applicable to a wide range of different substrate 
materials. 
 2. Experimental Section 
 2.1. Materials 
 All materials were purchased from Sigma–Aldrich and used 
without further puriﬁ cation unless otherwise indicated.  
www.MaterialsViews.com
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 The synthesis of the two precursors used in this study, 4-
pentaﬂ uorophenyl ester[2.2]paracyclophane and 4-ethynyl[2.2]
paracyclophane was described elsewhere. [ 8a , 15 ] CVD co-polymer-
ization was performed using 1:1 molar mixtures of the two pre-
cursors as shown in Scheme  1 . The precursors sublimated under 
0.3 mbar at temperatures above 100  ° C and were transferred 
in a stream of argon carrier gas (20 sccm) to the pyrolysis zone 
(560  ° C). Following pyrolysis, the diradicals were transferred into 
the deposition chamber, with the chamber wall temperature 
adjusted to 120  ° C and substrates cooled to 15  ° C to optimize the 
deposition. Moreover, rotation of the substrates ensured uniform 
ﬁ lm thickness. 
 2.3. Surface Characterization 
 IR spectroscopy was performed on a Nicolet 6700 spectrometer 
with the MCT-A detector and the grazing angle accessory (Smart 
SAGA) at a grazing angle of 80 ° . The coatings for IR characteriza-
tion were all controlled at 50–60 nm. XPS data were recorded on 
an Axis Ultra X-ray photoelectron spectrometer (Kratos Analyti-
cals, UK) equipped with a monochromatized AlK α X-ray source 
(takeoff angle 90 ° ). All spectra were calibrated with respect to 
the non-functionalized aliphatic carbon with a binding energy of 
285.0 eV. Thicknesses were measured by Imaging Spectroscopic 
Ellipsometer (Accurion, Nanoﬁ lm EP 3 -SE). Ellipsometric para-
meters were ﬁ tted using Cauchy model. The imaging lateral reso-
lution is  ≈ 2  μ m for the 10 × objective. 
 2.4. Immobilization of EGF 
 The procedure of immobilization of epidermal growth factor 
(EGF) and adhesion peptide is shown in Figure  2 a. Microcontact 
printing ( μ CP) was used in this study to conﬁ rm each immobiliza-
tion step. PDMS stamps were created as described elsewhere. [ 16 ] 
Stamps were oxidized for 20 min using UV-ozone cleaner before 
use. The stamps inked with EGF solution (10  μ g mL  − 1 in PBS) were 
kept in contact with the sample surface for 10 min. After stamp 
removal, the patterned samples were thoroughly washed with 
PBS. The immobilization reactions in solution without using  μ CP 
were the same as described above. The substrates immobilized 
with EGF were incubated with an anti-EGF antibody (a mouse IgG 
antibody) diluted in PBS containing 0.1% (w/v) bovine albumin 641
n. 2012,  33,  640−645
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 Figure  1 .  (a) Fourier transform infrared (FTIR) spectra for polymer 
 1 ,  2 , and  3 and (b): chemical composition in atom% shown as 
experimental value (calculated value in the bracket) determined 
by XPS; Experimental values of O and F atom ratios [%] were 
obtained from survey results and other experimental values are 
from high resolution C 1s spectra peak ﬁ tting calculated based on 
a equimolar distribution of starting materials. 
 Figure  2 .  (a) Scheme for CVD copolymerization, biomolecules immobilization, and 
potential cell responses. (b) Fluorescence micrograph of epidermal growth factor (EGF) 
immobilized in patterned area after  μ CP and immunostaining. (c1) Imaging ellipsometry 
thickness map of cRGD peptide pattern. (c2) Thickness proﬁ le representing thickness 
difference along the red line shown in (c1). and Tween 20 (0.02% (v/v)) (10  μ g mL  − 1 ) for 
1 h. After washing with the PBS/BSA/Tween 
buffer, the samples were incubated in the 
PBS/BSA/Tween buffer containing FITC con-
jugated antimouse IgG (10  μ g mL  − 1 ) for 1 h. 
The stained samples were then washed with 
PBS, rinsed with distilled water, and observed 
under a ﬂ uorescence microscope (Olympus 
BX-51, Japan). 
 2.5. Immobilization of the cRGD 
Peptide 
 cRGD peptide with an azide end group 
(cyclo(azidoK-RGDf), Kinexus, Canada) was 
dissolved in an aqueous solution of sodium 
ascorbate (50 mg mL  − 1 ) and copper(II) sulfate 
(0.1  × 10  − 3  M ). The peptide concentration was 
50  μ g mL  − 1 . The stamp inked with the peptide 
azide solution was then kept in contact with 
the sample surface for 4 h, followed by stamp 
removal and repeated washing with PBS and 
deionized water. The condition was the same 
for reaction in solution without using  μ CP. 
 3. Results and Discussion 
 To achieve controlled immobilization of 
multiple biomolecules, we ﬁ rst had to 
develop a polymer coating with multiple Macromol. Rapid Commu
© 2012  WILEY-VCH Verlag Gmfunctional groups, which can covalently bind to different 
molecules using bio-orthogonal reaction pathways. The 
copolymer to be developed in this study is poly[(4-ethynyl-
 p -xylylene)- co -(4-pentaﬂ uorophenyl ester- p -xylylene)- co -
( p -xylylene)] ( 3 ). Poly[(4-ethynyl- p -xylylene)- co -( p -xylylene)] 
( 1 ) and poly[(4-pentaﬂ uorophenyl ester- p -xylylene)- co -( p -
xylylene)] ( 2 ), which only have one of the two functional 
groups (either alkyne or pentaﬂ uorophenyl ester), are shown 
in Scheme  1 and Figure  1 for comparison. The Fourier trans-
form infrared (FTIR) spectrum of copolymer  3 shown in 
Figure  1 reveals characteristic bands of alkyne groups (3287 
and 2101 cm  − 1 ) and pentaﬂ uorophenyl ester groups (1762, 
1523, and 1250–990 cm  − 1 ). In addition, no sign of cross-
reactions between functional groups were observed during 
CVD polymerization. Next, the polymer ﬁ lms were analyzed by 
X-ray photoelectron spectroscopy (XPS), which has routinely 
been used to conﬁ rm the chemical composition of the outer-
most 10 nm of polymer ﬁ lms. The experimental values shown 
in Figure  1 are in good agreement with the calculated surface 
composition, which was obtained according to the chemical 
formula of the starting materials assuming stoichiometric 
conversion into the polymer. Detailed XPS analysis revealed  
www.MaterialsViews.com
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mately half of polymer  2, which only carries pentaﬂ uoroph-
enyl ester groups on the surface. It shows that by feeding 1:1 
molar ratio of the different precursors, approximately 1:1 ratio 
of each functional group was observed on the surface. 
 To conﬁ rm that the simultaneous surface conjugation 
of both the peptide and growth factor was feasible, micro-
contact printing was used to create patterned substrates 
of protein or peptide. Areas not modiﬁ ed during micro-
contact printing were used as an internal reference. The 
cRGD peptide was immobilized using click chemistry (i.e., 0
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 Figure  3 .  Fluorescence micrographs of HUVEC line seeded onto modiﬁ ed surfaces of 
polymer  3 after 4 h incubation. The surfaces were tethered with: (a) AEE, (b) cRGD-
only, (c) EGF-only, (d) cRGD  + EGF. (e) Quantiﬁ cation of spreading by ImageJ (three trials 
combined). Huisgen’s [1,3]dipolar cycloaddition 
catalyzed by Cu  +  ions), and EGF was 
tethered covalently by reaction with the 
highly reactive Pfp-ester group to form 
an amide bond with the terminal pri-
mary amine. Immunostaining was used 
to visualize the immobilized EGF. The 
polymer  3 coated substrates functional-
ized with EGF at the patterned area were 
incubated in anti-EGF antibody (primary 
antibody) solution, washed and then 
immersed in the solution of FITC conju-
gated antimouse IgG (secondary anti-
body). Figure  2 b shows that after immu-
nostaining of the entire surface, only 
the area with EGF showed ﬂ uorescence. 
This suggests that the active ester chem-
istry for growth factor immobilization 
(Figure  2 a) was successful. The cRGD 
peptide immobilization was character-
ized by imaging ellipsometry. Figure  2 c1 
and c2 show that the thickness of the 
area patterned with cRGD peptide via 
click chemistry was approximately 
0.5 nm higher than the unpatterned 
area, which conﬁ rmed that the cRGD 
peptide was immobilized on the surface 
of polymer  3 . 
 We then evaluated the immobilization 
of cRGD via click reaction and assessed 
peptide activity in the presence of immo-
bilized growth factor. The RGD tripep-
tide is a well-studied cell adhesion motif 
present in many proteins, but perhaps 
most prominently in extracellular matrix 
(ECM) molecules, such as ﬁ bronectin and 
vitronectin (among others). [ 17 ] RGD (and 
other small peptide adhesion molecules) 
have been widely explored for use in 
tissue engineering and presents several 
advantages over full-length proteins 
such as ﬁ bronectin, including issues such 
as enzymatic denaturation and overall  
www.MaterialsViews.com
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this study. The major advantages of these cyclic peptides 
are automatable synthesis, resistance against proteolysis, 
weak immunogenicity, high speciﬁ city to integrin  α v β 3 , 
and enhanced biological activity (up to 240 times of linear 
analogues). [ 19 ] Human umbilical vein endothelial cells 
(HUVEC) spreading on polymer  3 surfaces with different 
treatments was shown in Figure  3 . The surfaces were pas-
sivated with 2-(2-aminoethoxy)ethanol (AEE), [ 13d ] immo-
bilized only with cRGD, only with EGF or with both bio-
molecules, respectively. HUVEC spreading is signiﬁ cantly 643
n. 2012,  33,  640−645
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644enhanced by the presence of cRGD. The cell area on the 
surface with both cRGD and EGF was approximately the 
same as the one with only cRGD. The surface immobi-
lized only with EGF only had a slight increase in cell area. 
The observance that EGF did not have any obvious effect 
on HUVECs is consistent with other studies showing the 
absence of EGFR expression in normal HUVECs. [ 20 ] 
 Tethering growth factors has gained more interest from 
the scientiﬁ c community within the last three decades. [ 21 ] 
Studies showed that the immobilized growth factors, com-
pared to the soluble ones, had higher mitogenic effect, 
longer-term signal transduction and were resistant to 
endocytosis, degradation and diffusion. [ 22 ] In order to verify 
that the immobilized EGF still have biological activity, 0
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 Figure  4 .  Immunoﬂ uorescence of phosphorylated EGFR in A431 cell
coated surfaces with tethered (a) AEE, (b) cRGD, (c) EGF, and (D) cRGD +
tion of pEGFR immunoﬂ uorescence (three trials combined). 
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phosphorylation of EGFR (pEGFR), the receptor of EGF. The 
A431 line is a human epidermal carcinoma and a well-
characterized positive control for EGFR activity. [ 23 ] A431 
cells overexpress EGFR roughly 10–50-fold over many other 
cell lines, and thus are an ideal cell type for examining the 
bioactivity of tethered EGF. [ 24 ] Surfaces with tethered EGF 
successfully induce phosphorylation of EGFR in serum-
starved A431 cells, as observed using immunoﬂ uorescence 
(Figure  4 ). This shows that the immobilized EGF on polymer 
 3 maintained its biological activity. Surfaces exhibiting 
both the adhesion factor cRGD and EGF show statistically 
similar ( p  < 0.001) pEGFR phosphorylation compared to 
those exhibiting EGF alone, demonstrating that multiple RGD+EGF
*
s cultured on CVD-
 EGF. (e) Quantiﬁ ca-
un. 2012,  33,  640−645
bH &  Co.  KGaA, Weinhbiofactors do not affect this particular 
growth factor’s ability to interact with its 
receptor. We next examined A431 EGFR 
phosphorylation in response to soluble 
EGF and compared it to tethered EGF 
(Figure S1, Supporting Information). Var-
ious literature indicate that A431 respond 
to EGF with EC 50 values of 12.1 ng mL  − 1 
and 20 ng mL  − 1 , respectively. [ 25 ] From four 
independent trials, an average EC 50 value 
was 14.8 ng mL  − 1  ± 3.02 ng mL  − 1 (standard 
error), well matching the reported litera-
ture values previously cited. In all four 
trials, EGFR phosphorylation of tethered 
EGF as measured by quantiﬁ cation of 
immunoﬂ uorescence was either statis-
tically equivalent to or higher ( p  < 0.05) 
than the highest concentration of soluble 
EGF tested (1000 ng mL  − 1 ), demonstrating 
the potency of tethered EGF. 
 4. Conclusion 
 The herein developed immobilization 
scheme has been successfully developed 
to immobilize a peptide and a growth 
factor. In independent experiments, we 
have further been able to demonstrate 
biological activity of the respective factor 
in the presence of the second biomole-
cules. Future work include validating this 
technique for other growth factors and 
chemokines, tethering patterns of dif-
ferent factors to induce topology-speciﬁ c 
differentiation of human mesenchymal 
stem cells, and using two-source CVD 
to create precise gradients of factors for 
induction of differential morphogenesis 
in various epithelial lines.  
www.MaterialsViews.comeim
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